2021
DOI: 10.4040/jkan.21069
|View full text |Cite
|
Sign up to set email alerts
|

Validity and Reliability of Korean Version of the Self-Efficacy for Managing Chronic Disease 6-Item Scale

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…The participants' self-efficacy was assessed by the Self-Management Resource Center, which provides chronic disease management resources for research without requiring approval [18] . The tool used was the Self-Efficacy for Managing Chronic Disease 6-item scale (SECD-6) translated by Kim et al [19] . The tool consisted of 6 questions on a 10-point Likert scale, from 1 (not at all confident) to 10 (completely confident).…”
Section: Research Tools 241 Knowledge Of Portable Anti-cancer Infusersmentioning
confidence: 99%
“…The participants' self-efficacy was assessed by the Self-Management Resource Center, which provides chronic disease management resources for research without requiring approval [18] . The tool used was the Self-Efficacy for Managing Chronic Disease 6-item scale (SECD-6) translated by Kim et al [19] . The tool consisted of 6 questions on a 10-point Likert scale, from 1 (not at all confident) to 10 (completely confident).…”
Section: Research Tools 241 Knowledge Of Portable Anti-cancer Infusersmentioning
confidence: 99%
“…The 6-item SEMCD scale has been psychometrically evaluated in non-US contexts such as Brazil [ 10 ], Germany [ 11 ], Iran [ 12 ], South Korea [ 13 ], Portugal [ 14 ], Turkey [ 15 ], Sweden [ 16 ], France [ 17 ], Saudi Arabia [ 18 ] and Canada [ 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…The validation carried out in Korea [ 13 ] shows how sociodemographic data are evaluated through the association with quality of life and disease, identifying that for diseases such as arthritis and asthma the quality of life is lower than for patients with hypertension, an analysis that is achieved thanks to the validation of sociodemographic data that evaluate age, gender, disease and support in symptom management. Similar to the validation carried out in Sweden, where sociodemographic data are collected to analyze the quality of life in patients with chronic diseases, with which the scale is validated [ 16 ].…”
Section: Introductionmentioning
confidence: 99%